Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene.

Movement disorders : official journal of the Movement Disorder Society - 1 Jun 2015

Mirelman Anat, Alcalay Roy N, Saunders-Pullman Rachel, Yasinovsky Kira, Thaler Avner, Gurevich Tanya, Mejia-Santana Helen, Raymond Deborah, Gana-Weisz Mali, Bar-Shira Anat, Ozelius Laurie, Clark Lorraine, Orr-Urtreger Avi, Bressman Susan, Marder Karen, Giladi Nir

Abstract excerpt

BACKGROUND: The asymptomatic carriers of the Leucine rich repeat kinase 2 (LRRK2) G2019S mutation represent a population at risk for developing PD. The aim of this study was to assess differences in nonmotor symptoms between nonmanifesting carriers and noncarriers of the G2019S mutation. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies
Share to Heterozygote

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Mutation

Share to Parkinson Disease

Share to Prodromal Symptoms

Share to Protein Serine-Threonine Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 25809001
DOI: 10.1002/mds.26213
PMCID: PMC4478229

Genes

NMS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25809001-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene.PMID 25809001Read ↗

Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.Semantic proximity Read ↗

Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls.Semantic proximity Read ↗

Clinical Features of LRRK2 Carriers with Parkinson's Disease.Semantic proximity Read ↗

Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study.Semantic proximity Read ↗

The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.Semantic proximity Read ↗

Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers.Semantic proximity Read ↗

Subclinical signs in LRRK2 mutation carriers.Semantic proximity Read ↗

Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.Semantic proximity Read ↗

LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic.Semantic proximity Read ↗

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.Semantic proximity Read ↗

The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: clinical and demographic characteristics.Semantic proximity Read ↗

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.